Past Speakers

Ulrik is the Head of Global Pricing at Novo Nordisk. He has more than 10 years of pharmaceutical pricing, market access and commercial experience from industry and consulting. He has a Ph.D. and an M.Sc. degree in economics, both from the University of Copenhagen.

Patric is a senior pricing expert. He combines extensive experience as a pricing and sales consultant, speaker, and trainer with real proven hands-on practical implementation knowledge. He worked many years for top consultancies (Simon-Kucher, PwC, Accenture) and is currently heading the global pricing team at Boehringer Ingelheim. He brings insights from many different industries and knows how to transfer cross-industry best practices and develop innovative solutions. He is working in pricing for more than 18 years and is a well-received advisor for start-ups as well as for large organizations.

Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support commercial decisions, including pricing.

Alan has shared his expertise and insight and has spoken extensively at a number of pharmaceutical conferences on drug and device pricing. He was previously the CEO of Alliance Life Sciences and prior to that held positions as vice president in life sciences at Adjoined/Capgemini and as managing officer in Andersen Consulting, where he led a number of large technology projects.

Alan is a graduate of Princeton University.

Christian has over a decade of experience in global pricing within the pharmaceutical industry. He currently leads the Global Pricing function at Lundbeck, a company dedicated to restoring brain health. Christian and his team develop and implement innovative pricing strategies that enhance access to treatments while ensuring sustainable profitability. He aspires to leverage his extensive experience from both operational and strategic roles, facilitating actionable and impactful implementation of pricing strategies.

Natalie Mochova is a Global Strategic Pricing Manager at Zentiva, with over 10 years of experience in pricing across industries such as cybersecurity, industrial, banking and pharmaceuticals. Holding a PhD in Finance, Natalia specialises in developing innovative pricing strategies that drive business growth.

Alejandra Garitonandia is an Industry Principal for Life Sciences at Vistex EMEA. Her expertise and passion are in revenue management for pharma, medical device and animal health. A background in medical and business studies led to an international career spanning a variety of positions in business and IT. She is an international speaker and leads Life Sciences industry-driven initiatives focused on complex topics and trends.

Alejandra focuses on helping Life Sciences companies find their single source of truth where business processes meet IT systems to support efficient end-to-end revenue management​.

Nico Julian Mros is the Chief Customer Experience Officer and a co-founder of Lyfegen, a leading global provider of innovative drug access, pricing, and rebate management solutions. Since the company’s inception in 2018, Nico has been responsible for the implementation of over 2,500 value-based drug pricing contracts, across a diverse range of therapeutic areas including metabolic diseases, hematology, oncology, and central nervous system disorders. His work is driven by a commitment to improving healthcare delivery through practical, patient-centered approaches, with a particular focus on making high-cost therapies more accessible and affordable. Nico’s contributions have been instrumental in positioning Lyfegen as a key innovator with insurers, government bodies, payers, and pharmaceutical companies worldwide to establish and optimize the management of complex drug pricing agreements. Under his leadership, Lyfegen has rolled out cutting-edge platform products, including the world’s largest library of value-based contracts, a sophisticated drug contracting simulator, and an advanced agreement and rebate analytics platform. 

20+ years of Pharmaceutical & MedTech experience, enabled by an MBA, and Master’s in Health Economics - combined with Global & EMEA leadership roles at Novo Nordisk, Becton-Dickinson (BD), Baxter, BMS, and Eli Lilly, covering all regions.

25+ Global/EMEA product launches, following value-based pricing & access strategies. Experience with many therapeutic areas & product categories: general & specialty medicines, vaccines; medical devices, diagnostic products & services - including SaaS and platform-based solutions

Gianclaudio Floria is the founder and CEO of Bright Light Consulting. He brings 20+ years in Pricing and Market Access across Hemato-Oncology, Immuno-Oncology, Nephrology, and Infectious Diseases. Six Sigma Green Belt certified, with 15+ years in team management. Former Global Pricing Head for Multiple Myeloma and Lymphoma Pricing at BMS.  Held leadership roles at Alexion, Fresenius Kabi Biosimilars, Amgen, and Gilead Sciences. Author, speaker, and Microsoft MVP for Excel. MBA from Mib School of Management, degree in Political Economy Science from University of Trieste. Expert in Financial and BI IT tools, with a passion for AI.

Chirag is the Co-Founder & Director of Analytics at Pharmsight Research and Analytics, leading a team of 20 members. With 13 years of experience in Forecasting, Analytics, Pricing Management, Strategic Insights, and Real-World evidence generation, Chirag has collaborated with 10 of the top 20 pharmaceutical companies. He has established Centers of Excellence around Pricing Management, IRP, Performance Analytics, Commercial and Patient Analytics, Tender Management, and HEOR. Additionally, he has developed AI-enabled solutions for Pharma Analytics. Chirag holds an M.Sc in Physics and a Bachelor of Pharmacy from BITS Pilani.